---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-037842"
form_type: "8-K"
ticker: "CTNM"
cik: "0001855175"
company_name: "Contineum Therapeutics, Inc."
filed_at: "2025-12-15T23:59:59+00:00"
generated_at: "2026-05-16T13:15:35.223386+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Contineum prices upsized $90M public offering at $12.25/share; net proceeds ~$84.2M

## Summary
- 7,346,938 shares of Class A common stock sold at $12.25 per share, up from planned $75M.
- Underwriters have a 30-day option to purchase up to 1,102,040 additional shares.
- Net proceeds estimated at $84.2M after underwriting discounts and expenses.
- Joint book-runners: Goldman Sachs, Leerink Partners, Stifel, RBC, William Blair; Jones as manager.
- Offering closed December 15, 2025, with proceeds for general corporate purposes.

## SEC filing metadata
- accession: 0001437749-25-037842
- form_type: 8-K
- ticker: CTNM
- cik: 0001855175
- company_name: Contineum Therapeutics, Inc.
- filed_at: 2025-12-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855175/000143774925037842/0001437749-25-037842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855175/000143774925037842/ctnm20251214_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-037842
- JSON: https://secwatch.observer/filing/0001437749-25-037842.json
- Plain text: https://secwatch.observer/filing/0001437749-25-037842.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.